Wilkes J M, Kajimura M, Scott D R, Hersey S J, Sachs G
Department of Medicine, University of California, Los Angeles 90073.
J Membr Biol. 1991 Jun;122(2):97-110. doi: 10.1007/BF01872634.
Isolated rabbit gastric glands were used to study the nature of the muscarinic cholinergic responses of parietal cells. Carbachol (CCh, 100 microM) stimulation of acid secretion, as measured by the accumulation of aminopyrine, was inhibited by the M1 antagonist, pirenzepine, with an IC50 of 13 microM; by the M2 antagonist, 11,2-(diethylamino)methyl-1 piperidinyl acetyl-5,11-dihydro-6H-pyrido 2,3-b 1,4 benzodiazepin-6-one (AF-DX 116), with an IC50 of 110 microM; and by the M1/M3 antagonist, diphenyl-acetoxy-4-methylpiperidinemethiodide (4-DAMP), with an IC50 of 35 nM. The three antagonists displayed equivalent IC50 values for the inhibition of carbachol-stimulated production of 14CO2 from radiolabeled glucose, which is a measure of the turnover of the H,K-ATPase, the final step of acid secretion. Intracellular calcium levels were measured in gastric glands loaded with FURA 2. Carbachol was shown to both release calcium from an intracellular pool and to promote calcium entry across the plasma membrane. The calcium entry was inhibitable by 20 microM La3+. The relative potency of the three muscarinic antagonists for inhibition of calcium entry was essentially the same as for inhibition of acid secretion or pump related glucose oxidation. Image analysis of the glands showed the effects of carbachol, and of the antagonists, on intracellular calcium were occurring largely in the parietal cell. The rise in cell calcium due to release of calcium from intracellular stores was inhibited by 4-DAMP with an IC50 of 1.7 nM, suggesting that the release pathway was regulated by a low affinity M3 muscarinic receptor or state; Ca entry and acid secretion are regulated by a high affinity M3 muscarinic receptor or state, inhibited by higher 4-DAMP concentrations (greater than 30 nM), suggesting that it is the steady-state elevation of Ca that is related to parietal cell function rather than the [Ca]i transient. Displacement of 3H N-methyl scopolamine (NMS) binding to purified parietal cells by CCh showed the presence of two affinities for CCh, but only a single affinity for 4-DAMP and lower affinity for pirenzepine and AFDX 116, providing further evidence for the parietal cell location of the [Ca]i response. Elevation of steady-state [Ca]i levels with either ionomycin or arachidonic acid did not replicate M3 stimulation of acid secretion or glucose oxidation, hence elevation of [Ca]i is necessary but not sufficient for acid secretion.
采用分离的兔胃腺来研究壁细胞毒蕈碱胆碱能反应的性质。通过氨基比林蓄积量测定,卡巴胆碱(CCh,100微摩尔)刺激的胃酸分泌受到M1拮抗剂哌仑西平的抑制,IC50为13微摩尔;受到M2拮抗剂11,2 -(二乙氨基)甲基-1-哌啶基乙酰基-5,11-二氢-6H-吡啶并[2,3 -b][1,4]苯并二氮杂卓-6-酮(AF-DX 116)的抑制,IC50为110微摩尔;受到M1/M3拮抗剂二苯基乙酰氧基-4-甲基哌啶甲碘化物(4-DAMP)的抑制,IC50为35纳摩尔。这三种拮抗剂在抑制卡巴胆碱刺激的放射性标记葡萄糖生成14CO2方面表现出相当的IC50值,14CO2生成量是胃酸分泌最终步骤H,K-ATP酶周转率的一个指标。在加载了FURA 2的胃腺中测量细胞内钙水平。结果显示,卡巴胆碱既能从细胞内钙库释放钙,又能促进钙通过质膜进入细胞。20微摩尔的La3+可抑制钙的进入。这三种毒蕈碱拮抗剂抑制钙进入的相对效力与抑制胃酸分泌或泵相关葡萄糖氧化的效力基本相同。对胃腺的图像分析表明,卡巴胆碱及其拮抗剂对细胞内钙的作用主要发生在壁细胞。4-DAMP可抑制因细胞内钙库释放钙导致的细胞钙升高,IC50为1.7纳摩尔,这表明释放途径受低亲和力M3毒蕈碱受体或状态调控;钙进入和胃酸分泌受高亲和力M3毒蕈碱受体或状态调控,更高浓度的4-DAMP(大于30纳摩尔)可抑制这种调控,这表明与壁细胞功能相关的是钙的稳态升高而非细胞内钙瞬变。CCh对纯化壁细胞上3H N-甲基东莨菪碱(NMS)结合的置换显示,CCh存在两种亲和力,但4-DAMP只有一种亲和力,对哌仑西平和AF-DX 116的亲和力较低,这为细胞内钙反应定位于壁细胞提供了进一步证据。用离子霉素或花生四烯酸升高细胞内钙稳态水平并不能复制M3对胃酸分泌或葡萄糖氧化的刺激作用,因此细胞内钙升高对于胃酸分泌是必要的,但并不充分。